GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral Hemorrhage

Intracerebral Hemorrhage (ICH) Clinical Trial

Official title:
GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral Hemorrhage

Status Terminated

Clinical Trial Summary

The objective of this study is to assess the safety of GLP-1 CellBeads® in patients with space-occupying intracerebral hemorrhage.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01298830
Study type	Interventional
Source	CellMed AG, a subsidiary of BTG plc.
Contact
Status	Terminated
Phase	Phase 1/Phase 2
Start date	October 2008
Completion date	June 2011

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT01836848` - Non-invasive Measuring of Cerebral Perfusion After Severe Brain Injury With Near-infrared-spectroscopy and ICG	N/A
Completed	`NCT03338998` - Efficacy, Safety and Tolerability of BAF312 Compared to Placebo in Patients With Intracerebral Hemorrhage (ICH).	Phase 2
Completed	`NCT02670824` - Safety Study of CN-105 Neuroprotective Peptide for Intracerebral Hemorrhage	Phase 1
Active, not recruiting	`NCT04805177` - Early Minimally Invasive Image Guided Endoscopic Evacuation of Intracerebral Haemorrhage	N/A